WXIBF News and Press, Wuxi Biologics Cayman Inc

2026-02-13 05:45:00 ET The following segment was excerpted from the Baird International And Global Growth Funds Q4 2025 Commentary And Market Outlook. ... Read the full article on Seeking Alpha For further details see: Baird Chautauqua In...

2026-01-14 20:05:58 ET WuXi Biologics (Cayman) Inc. (WXXWY) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 11:15 AM EST... Read the full article on Seeking Alpha For further details see: WuXi Biologics (Cayman) Inc. (WXXWY) Presents at 44th Annual J.P. Morgan...

2025-08-06 09:24:00 ET Dear Baron Emerging Markets Fund Shareholder: Baron Emerging Markets Fund ® (the Fund) gained 15.39% (Institutional Shares) during the second quarter of 2025, while its primary benchmark, the MSCI Emerging Markets Index (the Benchmark), appreciated 11...

2025-05-22 08:05:00 ET Summary Global equity markets diverged in Q1 2025, with U.S. equities underperforming due to aggressive tariffs and geopolitical tensions, while Europe and China showed resilience. Our investment strategy emphasizes long-term secular growth trends, strong co...

2025-05-18 04:04:32 ET Summary I have lowered my rating for WuXi Biologics from a Buy to a Hold, taking into consideration its financial prospects and risk factors. In the long run, the onshoring of drug manufacturing in the U.S. might limit WuXi's growth potential for the long ru...

2025-04-28 08:09:00 ET Summary Baron Emerging Markets Fund increased in the first quarter of 2025, outperforming its benchmark, the MSCI EM Index. Emerging markets equities outperformed as the uncertainty generated by Trump’s tariff war spurred a broad-based rotation out of...

2025-04-24 01:25:00 ET Summary Emerging markets equities demonstrated resilience in Q1 against a backdrop of heightened geopolitical uncertainty and shifting macroeconomic dynamics. Top relative contributors in Q1 included Gentera, Wuxi Biologics and MTN Group. During Q1, we i...

2025-04-09 18:53:16 ET Below are the top 5 penny stocks screened from our system based on their highest market capitalization, traded volume and 1-Day Change% in Healthcare sector. WuXi Biologics (Cayman) Inc. (WXIBF) WXIBF is trading UP for the last 1 days, and it at trading at $...

2025-02-11 09:52:00 ET Summary Invesco Developing Markets Fund Class A shares outperformed the MSCI EM Index. Stock selection in the consumer discretionary sector added to relative return. The largest detractor from relative return was stock selection and an underweight in financi...

2025-01-21 17:18:58 ET Summary My rating upgrade for WuXi Biologics to a Buy has taken into consideration its latest corporate move and business disclosures. The sale of its European manufacturing facility will throw up margin improvement and capital allocation opportunities for W...